Skip to Content

Positive results with filgotinib for ulcerative colitis from ECCO23

Filgotinib effectively maintains symptomatic remission and health-related quality of life for up to approximately 4 years among patients with ulcerative colitis.

Get access

If you are a doctor, nurse, or other health professionals, you can access the entire article by creating a profile on BestPractice Nordic.

Back to top